Japan grants ODD to Merck's investigational therapy Tepotinib

Merck, a leading science and technology company, has announced that the Japanese Ministry of Health, Labour and Welfare ...

November 21, 2019 | Thursday | News
Toray signs pact with JICA to support infection control capacity

Japan headquartered Toray Industries, Inc., has made an agreement with the Japan International Cooperation Agency (JICA)...

November 20, 2019 | Wednesday | News
Novartis to buy Aspen's Japanese operations

Sandoz has announced that it has entered into a binding agreement for the planned acquisition of the Japanese business o...

November 18, 2019 | Monday | News
Lupin bids goodbye to Japan

Indian pharma major Lupin Limited (including its subsidiaries, together referred to as  ‘Lupin’) a...

November 18, 2019 | Monday | News
Clinical Trial of Boron Neutron Capture Therapy commences in Japan

Cancer Intelligence Care Systems, Inc. (CICS) and STELLA PHARMA CORPORATION will commence a Phase I clinical trial of Bo...

November 18, 2019 | Monday | News
Takeda announces 12 new molecular entities

Japan headquartered Takeda Pharmaceutical Company Limited recentky hosted an R&D meeting in New York City to ou...

November 15, 2019 | Friday | News
NEC, VAXIMM to advance personalized neoantigen cancer vaccines

Japan based NEC Corporation, a leader in IT and network technologies, and VAXIMM AG, a Swiss/German biotech company focu...

November 15, 2019 | Friday | News
Yokogawa acquires nanopipette technology for life science applications

Japan headquartered Yokogawa Electric Corporation announces that it has acquired a nanopipette technology that was devel...

November 14, 2019 | Thursday | News
Novo Nordisk obtains worldwide licence to potential NASH candidate

Novo Nordisk A/S and Japanese chemical company UBE Industries Ltd. recently announced that Novo Nordisk has obtained an ...

November 8, 2019 | Friday | News
Takeda, Anderson Cancer Center accelerate cell therapy

University of Texas MD Anderson Cancer Center (The University of Texas MD Anderson Cancer Center) and Takeda P...

November 12, 2019 | Tuesday | News
Kayentis opens Japanese subsidiary

Kayentis, a global provider of eCOA (electronic Clinical Outcome Assessment) solutions for clinical trials, has announce...

November 11, 2019 | Monday | News
Fujitsu improves efficiency in Cancer Genomic Medicine in joint AI research

Fujitsu, on 7 Nov 2019, announced the results of a joint research project it has been conducting with the Institute of M...

November 8, 2019 | Friday | News
Takeda's Dengue vaccine candidate reveals protection in children

Japan based Takeda Pharmaceutical Company Limited has announced that results from the primary endpoint analysis of ...

November 8, 2019 | Friday | News
Hitachi collaborates with CLB to fight cancer using AI

Tokyo headquartered Hitachi, Ltd. and Centre Leon Berard (CLB), a leading French Comprehensive Cancer Center in Lyon-Fra...

November 7, 2019 | Thursday | News
Olympus unveils corporate strategy

Olympus Corporation has announced its Corporate Strategy in central Tokyo. The announcement follows the company's e...

November 7, 2019 | Thursday | News
Takeda divests select products to STADA for $660M

Japan based Takeda Pharmaceutical Company Limited has announced that it has entered into an agreement to divest a portfo...

November 6, 2019 | Wednesday | News
Fujifilm's rapid TB diagnostic kit receives recognition

FUJIFILM Corporation is pleased to announce that its “Rapid Tuberculosis Diagnostic Kit” has won the Good De...

November 5, 2019 | Tuesday | News
Synthetic compound provides fast screening for potential drugs

A simple assay may benefit drug discovery for treating diabetes, Parkinson's, and Alzheimers disease, as well as studies...

November 4, 2019 | Monday | News
Promethera Biosciences spreads business activity to Japan

Promethera Biosciences SA (Group), a global innovator in cell-based medicines and liver diseases, had announced the foun...

November 4, 2019 | Monday | News
EMA and FDA accept marketing applications for Chugai's Satralizumab

Chugai Pharmaceutical has announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Ap...

October 31, 2019 | Thursday | News
Pandion, Astellas collaborate for pancreas targeted immunomodulators

US headquartered Pandion Therapeutics, Inc., and Japan based Astellas Pharma Inc. have announced the signing of a Licens...

October 31, 2019 | Thursday | News
Lobsor Pharma receives Japanese patent for APD solution

Lobsor Pharmaceuticals AB, a privately held Swedish company based in Uppsala, has announced the Japanese Patent Office h...

November 1, 2019 | Friday | News
Hitachi takes advanced Proton Therapy to the US

Japan headquartered Hitachi, Ltd., has announced that it has provided its advanced proton therapy system to Sibley Memor...

October 31, 2019 | Thursday | News
Biogen plans regulatory filing for Aducanumab for Alzheimer's

Biogen and Eisai, Co., Ltd. (Tokyo, Japan) has announced that, after consulting with the U.S. Food and Drug Administrati...

October 23, 2019 | Wednesday | News
MIMS and Ashfield Communications combine operations in Japan

MIMS Group, Asia's largest multi-channel provider of drug information, medical communications, events management and mar...

October 24, 2019 | Thursday | News